With a market cap of $18.8 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company that designs, manufactures, and markets innovative orthopedic reconstructive products, sports medicine solutions, biologics, and surgical technologies. The company serves healthcare professionals worldwide with advanced products that treat disorders and injuries of bones, joints, and soft tissues. The Warsaw, Indiana-based company is slated to announce its fiscal Q3 2025 results before the market ...